Cite
Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT-1). A single-arm feasibility study evaluating the safety and potential benefit of the Ischemic Stroke System for treatment of acute ischemic stroke.
MLA
Khurana, Dheeraj, et al. “Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT-1). A Single-Arm Feasibility Study Evaluating the Safety and Potential Benefit of the Ischemic Stroke System for Treatment of Acute Ischemic Stroke.” PLoS ONE, vol. 14, no. 7, July 2019, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0217472.
APA
Khurana, D., Kaul, S., Schneider, D., Csanyi, A., Adam, I., Ichaporia, N. R., Griewing, B., Csiba, L., Valikovics, A., Puri, V., Diener, H. C., Schwab, S., Hetzel, A., Bornstein, N., & null, null. (2019). Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT-1). A single-arm feasibility study evaluating the safety and potential benefit of the Ischemic Stroke System for treatment of acute ischemic stroke. PLoS ONE, 14(7), 1–14. https://doi.org/10.1371/journal.pone.0217472
Chicago
Khurana, Dheeraj, Subhash Kaul, Dietmar Schneider, Attila Csanyi, Ilona Adam, Nasli R. Ichaporia, Bernd Griewing, et al. 2019. “Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT-1). A Single-Arm Feasibility Study Evaluating the Safety and Potential Benefit of the Ischemic Stroke System for Treatment of Acute Ischemic Stroke.” PLoS ONE 14 (7): 1–14. doi:10.1371/journal.pone.0217472.